Evestia, Clinical

Evestia Clinical - the new brand identity for EMAS Pharma - launches today as a market leading pharmaceutical research specialist focussed on Clinical Trials in Oncology and Rare Diseases

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Evestia Clinical England United States of America United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/evestia-clinical---the-new-brand-identity-for-emas-pharma---launches-today-as-a-market-leading-pharmaceutical-research-specialist-focussed-on-clinical-trials-in-oncology-and-rare-diseases-302407194.html

en | CA7609751028 | EVESTIA | boerse | 67919884 |